Question-and-Answer SessionI think from first question standpoint, I'm sensing a lot of anxiety from investors just around the P&C pricing cycle broadly. And so I wanted to see if you could discuss what you're seeing in Hartford's markets? And any views you might be able to offer up around softening and how will it play out, how impactful is it for your business versus some of the things you all are doing to compound book value in the meantime regardless.Christopher SwiftChairman & CEO Yes. Well, I'll just ...

Key Takeaways EHC's occupancy rose from 72.1% in 2023 to 77.7% in the first half of 2025.Patient discharges climbed 8.7% in 2023, 8.3% in 2024, and 6.8% in early 2025.Adjusted net margin improved from 7.7% in 2023 to 9.7% in the first half of 2025.Encompass Health Corporation (EHC) is proving that smart expansion and operational discipline can deliver meaningful results. Fueled by an aging population and growing demand for inpatient rehabilitation, volumes keep rising while the company has steadily widened ...

Key Takeaways UnitedHealth reaffirmed its 2025 EPS guidance despite dilution from the Amedisys deal.Analysts cut UNH earnings estimates, projecting EPS to fall even as revenue climbs.UNH faces rising medical loss ratios, regulatory probes and a steep share price drop.UnitedHealth Group Incorporated (UNH) is set to reaffirm its 2025 adjusted EPS outlook in upcoming meetings with investors and analysts, even as the recent Amedisys acquisition is expected to be “modestly dilutive” to earnings because of financ ...

Key Takeaways Investors await Fed's Sept. 16-17 meeting, with a rate cut seen as nearly certain.HALO, PARR, BPOP, PHIN and KT made the screen with earnings yields above 10% and strong growth.Screening also required EPS growth, high trading volume, price above $5 and buy ratings.Wall Street closed in the green yesterday, with all three major indexes inching higher. The Nasdaq Composite gained 0.45% to reach a record 21,798.70, while the S&P 500 added 0.21% to end at 6,495.15. The Dow also climbed roughly 114 ...

The price trend for CorMedix (CRMD) has been bearish lately and the stock has lost 14% over the past week. However, the formation of a hammer chart pattern in its last trading session indicates that the stock could witness a trend reversal soon, as bulls might have gained significant control over the price to help it find support.While the formation of a hammer pattern is a technical indication of nearing a bottom with potential exhaustion of selling pressure, rising optimism among Wall Street analysts abou ...

Astria Therapeutics, Inc. (ATXS) closed the last trading session at $7.43, gaining 11.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $29.33 indicates a 294.8% upside potential.The average comprises nine short-term price targets ranging from a low of $16.00 to a high of $49.00, with a standard deviation of $9.19. While the lowest estimate indicates an increase of 115.3% from the ...

Shares of Carpenter Technology (CRS) have gained 1.4% over the past four weeks to close the last trading session at $251.88, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $318 indicates a potential upside of 26.3%.The mean estimate comprises five short-term price targets with a standard deviation of $31.94. While the lowest estimate of $300.00 indicates a 19.1% increase from t ...

Shares of Sionna Therapeutics, Inc. (SION) have gained 7.9% over the past four weeks to close the last trading session at $21.62, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $36 indicates a potential upside of 66.5%.The average comprises four short-term price targets ranging from a low of $22.00 to a high of $45.00, with a standard deviation of $11.17. While the lowest estim ...

Schrodinger, Inc. (SDGR) closed the last trading session at $19.44, gaining 4.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $27.3 indicates a 40.4% upside potential.The average comprises 10 short-term price targets ranging from a low of $19.00 to a high of $33.00, with a standard deviation of $5.01. While the lowest estimate indicates a decline of 2.3% from the current price l ...

Sezzle Inc. (SEZL) closed the last trading session at $88, gaining 0.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $131.67 indicates a 49.6% upside potential.The average comprises three short-term price targets ranging from a low of $111.00 to a high of $150.00, with a standard deviation of $19.6. While the lowest estimate indicates an increase of 26.1% from the current price ...